col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


22 Ergebisse       Seite 1

 [1] 
Elsevier: JHEP Reports
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Nov―01 Alcohol Associated Hepatitis Trends Before and Following the Onset of the COVID-19 Pandemic Across Two Distinct Cohorts in the United States and Hong Kong Zeyuan Yang, Vicki Wing-Ki Hui, Terry Cheuk-Fung Yip, Mandy Sze-Man Lai, Jimmy Che-To Lai, Vincent Wai-Sun Wong, et al. (+3)
2 [GO] 2024―Aug―23 Impact of SARS-CoV-2 Vaccination in Patients with Vascular Liver Diseases: Observations from a VALDIG Multicenter Study Valeria Perez-Campuzano, Pierre-Emmanuel Rautou, Thomas Marjot, Michael Praktiknjo, Edilmar Alvarado, Laura Turco, et al. (+25)
3 [GO] 2023―Okt―13 SARS-CoV-2 receptor ACE2 is upregulated by fatty acids in human MASH Luis Cano, Lise Desquilles, Gevorg Ghukasyan, Gaëlle Angenard, Clémence Landreau, Anne Corlu, et al. (+6)
4 [GO] 2023―Aug―22 Splanchnic vein thrombosis associated with SARS-CoV-2 infection: a VALDIG case-control study Pierre Deltenre, Audrey Payancé, Laure Elkrief, Vincenzo La Mura, Florent Artru, Anna Baiges, et al. (+12)
5 [GO] 2023―Feb―20 Infection prevention and control program and COVID-19 measures: Effects on hospital-acquired infections in patients with cirrhosis Simone Di Cola, Jakub Gazda, Lucia Lapenna, Giancarlo Ceccarelli, Manuela Merli
6 [GO] 2023―Feb―20 Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease André Lopes Simão, Carolina Santos Palma, Laura Izquierdo-Sanchez, Antonella Putignano, Angela Carvalho-Gomes, Andreas Posch, et al. (+21)
7 [GO] 2022―Okt―13 Histological and serological features of acute liver injury after SARS-CoV-2 vaccination Greta Codoni, Theresa Kirchner, Bastian Engel, Alejandra Maria Villamil, Cumali Efe, Albert Friedrich Stättermayer, et al. (+33)
8 [GO] 2022―Aug―27 Impact of the COVID-19 pandemic on the care and outcomes of patients with NAFLD-related cirrhosis Jesús Rivera-Esteban, Ramiro Manzano-Nuñez, Teresa Broquetas, Isabel Serra-Matamala, Octavi Bassegoda, Agnès Soriano-Varela, et al. (+7)
9 [GO] 2022―Jul―27 Impact of the COVID-19 pandemic on hepatitis B and C elimination: an EASL survey Loreta A. Kondili, Maria Buti, Mar Riveiro-Barciela, Mojca Maticic, Francesco Negro, Thomas Berg, Antonio Craxì
10 [GO] 2022―Apr―28 Impaired SARS-CoV-2-specific T cell reactivity in patients with cirrhosis following mRNA COVID-19 vaccination Samer Al-Dury, Johan Waern, Jesper Waldenström, Marko Alavanja, Hevar Hamah Saed, Andreas Törnell, et al. (+8)
11 [GO] 2021―Mai―08 Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis Savneet Kaur, Sadam Hussain, Kailash Kolhe, Guresh Kumar, Dinesh M. Tripathi, Arvind Tomar, et al. (+7)
12 [GO] 2021―Mai―04 Top level research in hepatology: COVID-19 and beyond Sven Francque
13 [GO] 2021―Feb―24 Abnormal liver tests in patients with SARS-CoV-2 or influenza - prognostic similarities and temporal disparities Noa Shafran, Assaf Issachar, Tzippy Shochat, Inbal Haya Shafran, Michael Bursztyn, Amir Shlomai
14 [GO] 2021―Feb―23 Assessing the impact of COVID-19 on liver cancer management (CERO-19) Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, Jean-Charles Nault, Gonzalo Sapisochin, Lorenza Rimassa, et al. (+79)
15 [GO] 2021―Jan―19 Effects of a reorganization of cirrhosis care during the lockdown for SARS-CoV-2 outbreak Salvatore Piano, Marco Marzioni, Paolo Angeli, Marta Tonon, Marta Mazzetti, Valeria Calvino, et al. (+2)
16 [GO] 2021―Jan―12 Celebrating the third year of JHEP Reports in the COVID-19 era Sophie Lotersztajn
17 [GO] 2020―Okt―31 Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area Giuliana Amaddeo, Raffaele Brustia, Manon Allaire, Marie Lequoy, Clémence Hollande, Hélène Regnault, et al. (+23)
18 [GO] 2020―Aug―04 Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic Tobias Boettler, Thomas Marjot, Philip N. Newsome, Mario U. Mondelli, Mojca Maticic, Elisa Cordero, et al. (+4)
19 [GO] 2020―Jul―15 “Cirrhosis management in a major referral center during COVID-19” Isabel Garrido, Rodrigo Liberal, Rui Gaspar, Guilherme Macedo
20 [GO] 2020―Jul―03 Quality and reproducibility during the COVID-19 pandemic Thierry Gustot
21 [GO] 2020―Mai―24 Innovative liver research continues during the current pandemic Sven Francque
22 [GO] 2020―Apr―02 Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper Tobias Boettler, Philip N. Newsome, Mario U. Mondelli, Mojca Maticic, Elisa Cordero, Markus Cornberg, Thomas Berg
 [1] 

22 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec